Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Cidara Therapeutics, Inc. (CDTX) had Weighted-Average Shares Outstanding (Basic) of 14.18M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-23.48M |
|
-- |
|
-- |
|
$25.27M |
|
$-25.27M |
|
$1.79M |
|
$-23.48M |
|
$-23.48M |
|
$-23.48M |
|
$-23.48M |
|
$-23.48M |
|
$-23.48M |
|
$-25.27M |
|
$-25.22M |
|
|
Weighted-Average Shares Outstanding (Basic) |
14.18M |
14.18M |
|
$-1.66 |
|
$-1.66 |
|
| Balance Sheet Financials | |
$188.85M |
|
$0.35M |
|
$2.88M |
|
$191.73M |
|
$48.81M |
|
-- |
|
$1.24M |
|
$50.05M |
|
$141.68M |
|
$141.68M |
|
$141.68M |
|
12.21M |
|
| Cash Flow Statement Financials | |
$-21.95M |
|
$0.18M |
|
$0.08M |
|
$196.18M |
|
$174.49M |
|
$-21.69M |
|
$1.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.57% |
|
-16.57% |
|
-12.25% |
|
-16.57% |
|
$11.60 |
|
$-1.54 |
|
$-1.55 |
|